Celsion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

[at noodls] – LAWRENCEVILLE, NJ — (Marketwire) — 11/06/12 — Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that Michael H. Tardugno, Celsion’s President and Chief … more

View todays social media effects on CLSN

View the latest stocks trending across Twitter. Click to view dashboard